Neutrophilic dermatosis and hidradenitis suppurativa in patients with Behçet's disease: A neutrophilic disease in the spectrum of autoinflammatory syndromes.

• Pyoderma gangrenosum seems overrepresented in patients with Behçet's disease. • The clinical course of neutrophilic dermatosis may not correlate with Behçet's disease activity and treatment may be challenging. • Biotherapies such as anti-TNFα, ustekinumab and tocilizumab appear to be promising to...

Descripción completa

Detalles Bibliográficos
Publicado en:Seminars in Arthritis & Rheumatism Vol. 61
Autores principales: Bugaut, Hélène, Barete, Stéphane, Bagot, Martine, Bouaziz, Jean-David, Le Pelletier de Glatigny, François, Gallien, Yves, Biard, Lucie, Domont, Fanny, Cacoub, Patrice, Saadoun, David, Comarmond, Cloé
Formato: research Journal Article
Publicado: W B Saunders Aug2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164863298&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 164863298
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00490172
        4GQ
      jtl: Seminars in Arthritis & Rheumatism
      issn: 00490172
      maglogo: N
    pubinfo:
      dt: Aug2023
      vid: 61
      pid: 1351
      pub: W B Saunders
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        164863298
        164863298
        164863298
        10.1016/j.semarthrit.2023.152224
        164863298
      ppct: 1
      formats:
      tig:
        atl: Neutrophilic dermatosis and hidradenitis suppurativa in patients with Behçet's disease: A neutrophilic disease in the spectrum of autoinflammatory syndromes.
      aug:
        au:
          Bugaut, Hélène
          Barete, Stéphane
          Bagot, Martine
          Bouaziz, Jean-David
          Le Pelletier de Glatigny, François
          Gallien, Yves
          Biard, Lucie
          Domont, Fanny
          Cacoub, Patrice
          Saadoun, David
          Comarmond, Cloé
        affil: Department of Internal Medicine and Clinical Immunology, Sorbonne University, Pitié-Salpêtrière Hospital, APHP, 75013 Paris France, Centre de référence Maladies Autoimmunes systémiques rares, Centre de référence Maladies Autoinflammatoires et amylose, 83 boulevard de l'hôpital, Paris 75013, France
      sug:
        subj:
          Sweet's Syndrome Complications
          Hidradenitis Suppurativa Complications
          Behcet's Syndrome Risk Factors
          Hereditary Autoinflammatory Diseases
          Human
          Pyoderma Gangrenosum
          Biological Therapy
          Colchicine
          Glucocorticoids
      ab: • Pyoderma gangrenosum seems overrepresented in patients with Behçet's disease. • The clinical course of neutrophilic dermatosis may not correlate with Behçet's disease activity and treatment may be challenging. • Biotherapies such as anti-TNFα, ustekinumab and tocilizumab appear to be promising to treat refractory neutrophilic dermatosis and hidradenitis suppurativa associated with Behçet's disease. Association of neutrophilic dermatosis (ND), hidradenitis suppurativa (HS) and Behçet's disease (BD) and shared efficacy of TNFα axis blockade suggests common physiopathology. To investigate the clinical features and therapeutic response of ND and HS associated with BD. We identified 20 patients with ND or HS associated with BD among 1462 patients with BD. We analysed 20 (1.4%) patients diagnosed with ND or HS associated with BD: 13 HS, 6 pyoderma gangrenosum (PG), and 1 SAPHO. Our 6 PG cases over 1462 BD patients accounts for 400/100 000 prevalence. Thirteen had bipolar aphthosis, 6 vascular, 5 neurologic, and 4 ocular involvements. All PG occurred on limbs and had typical histology with constant dermal neutrophilic infiltrate. All HS had the classical axillary-mammary phenotype. Sixty-nine percent (69%) of HS were Hurley 1 stage. Treatment consisted mainly in colchicine (n = 20), glucocorticoids (n = 12), and anti-TNFα (n = 9). Interesting results with complete or partial responses were obtained with anti-TNFα (9 cases), ustekinumab (3 cases) and tocilizumab (1 case) to treat refractory ND or HS associated with BD. PG seems overrepresented in patients with BD. Biotherapies such as anti-TNFα, ustekinumab and tocilizumab appear to be promising to treat refractory ND or HS associated with BD. [Display omitted]
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N